Norton Rose Fulbright advises start-ups and established life sciences clients on product liability, antitrust, and IP matters. On the product liability side, the firm has experience defending and coordinating individual cases and MDLs. Its antitrust practice handles litigations, mergers, government investigations, and enforcement, while its IP work spans enforcement, prosecution, and litigation. The practice is co-led from Dallas by D’Lesli Davis, a lead trial counsel in mass tort cases who also represents corporate clients in product liability litigation, and Jonathan Skidmore, vastly experienced in mass torts and product liability. Strengthening the IP team, counselor Rhiannon D’Agostin joined the Denver office, while Adam Rehm, who focuses on IP prosecution, licensing, and litigation, joined the Dallas team; both arrived from Polsinelli PC.
Legal 500 redaktioneller Kommentar
- Profil
Kernmandanten
- Takeda Pharmaceutical Company Ltd.
- Eli Lilly and Company
- Millar Holding, Inc.
- Valeant Pharmaceuticals North America LLC (now known as Bausch Health US, LLC)
- Valeant Pharmaceuticals International (now known as Bausch Health Americas, Inc.)
- Oceanside Pharmaceuticals, Inc.
- Alaunos Therapeutics, Inc.
- CVS Pharmacy, Inc.
- Walgreen Co.
- Sprouts Farmers Market, Inc.
Highlight-Mandate
- Advised Takeda and Eli Lilly in defense of a nationwide RICO class action brought by a third-party payor health plan and individual consumers.
- Advises Cincinnati Children’s Hospital Medical Center in its entire patent portfolio for stem cell based regenerative medicine division.
- Advised Millar Holding, Inc. in its acquisition of Sentron, Inc., a renowned and fully integrated pressure and pH sensor manufacturing company headquartered in Leek, The Netherlands.
Anwält*innen
Praxisleitung
D’Lesli Davis; Jonathan Skidmore
Weitere Kernanwält*innen
Gina Shishima; Robin Adelstein; Rhiannon D’Agostin; Adam Rehm; Rajiv Khanna; Roger Kuan; Jason Novak; Mark Faccenda